Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04962126
Title Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy (FLUORO)
Acronym FLUORO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Ballarat Health Service Ballarat Victoria Australia Details
Eastern Health Box Hill Victoria 3128 Australia Details
Austin Health Heidelberg Victoria 3078 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field